Point of Care Testing (POC) is defined as medical diagnostic testing performed outside the clinical laboratory in close proximity to where the patient is receiving care.
Scope
- Extensive coverage of the HIV Point of care (POC) Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of HIV Point of care (POC) Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy
The report enables you to:- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of HIV Point of care (POC) Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Rapid Diagnostics GmbH
- Access Bio Inc
- Aldatu Biosciences Inc
- Altratech Ltd
- Atomo Diagnostics Ltd
- BBB Technologies Inc
- Beijing Wantai Biological Pharmacy Enterprise Co Ltd
- Binx Health Inc
- Bio-AMD Inc
- Biocartis Group NV
- BioHelix Corp
- Bluejay Diagnostics Inc
- Calypte Biomedical Corporation
- Centre International de Reference Chantal Biya
- Cepheid Inc
- ChipCare Corp
- CrossLife Technologies Inc
- Daktari Diagnostics, Inc.
- Diagnostics For All Inc
- Diagnostics for the Real World (Europe) Ltd
- Endeavor Sciences Inc
- Epinex Diagnostics Inc
- ERBA Molecular Ltd
- Fluxergy LLC
- GAIA Medical Institute LLC
- genedrive plc
- Group K Diagnostics
- Guangzhou Wondfo Biotech Co Ltd
- HeatFlow Technologies Inc
- Identifysensors LLC
- Imperial College London
- Integrated Diagnostics Inc (Inactive)
- Jan Biotech Inc
- Jinvator Bio Med GmbH
- Johns Hopkins University
- Maxim Biomedical Inc
- MedMira Inc
- Micronics Inc
- Molbio Diagnostics Pvt Ltd
- MyMD Pharmaceuticals, Inc
- Nanobiosym Inc
- Newmark Diagnostics LLC
- Northwestern University
- Osel Inc
- Prenetics Ltd
- QuantuMDx Group Ltd
- Quidel Corp
- Radisens Diagnostics Ltd
- Rheonix Inc
- Roche Diagnostics International Ltd
- Sedia Biosciences Corp
- Senzo Inc
- TheoremDx Inc
- Trinity Biotech Plc
- University of Connecticut
- University of Minnesota
- UrSure Inc
- Ustar Biotechnologies (Hangzhou) Ltd.
- Wave 80 Biosciences Inc
- Yaathum Biotech Pvt Ltd

